The Predictive Value of Longitudinal Monitoring of Mutated EGFR in Plasma of Advanced NSCLC Patients on First-Line EGFR-TKIs

被引：0
|
作者：
Szpechcinski, A. [1 ]
Bryl, M. [2 ]
Wojda, E. [1 ]
Czyzewicz, G. [3 ]
Swiniuch, D. [4 ]
Szwiec, M. [5 ]
Ramlau, R. [4 ]
Sliwinski, P. [1 ]
Barinow-Wojewodzki, A. [2 ]
Chorostowska-Wynimko, J. [1 ]
机构：
[1] Inst TB & Lung Dis, Warsaw, Poland
[2] EJ Zeyland Wielkopolska Ctr Pulmonol & Thorac Sur, Poznan, Poland
[3] John Paul II Specialist Hosp, Krakow, Poland
[4] Med Univ Poznan, Poznan, Poland
[5] Univ Hosp Zielona Gora, Zielona Gora, Poland
来源：
JOURNAL OF THORACIC ONCOLOGY | 2022年 / 17卷 / 09期
关键词：
non-small cell lung cancer; EGFR mutations; liquid biopsy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP08.02-07
引用
收藏
页码：S434 / S435
页数：2
相关论文
共 50 条
  • [1] Dynamic Monitoring and Predictive Value of Circulating Tumor Cells in EGFR Mutant Advanced NSCLC Patients Treated with First-Line EGFR-TKIs
    Su, C.
    Jiang, T.
    Zhao, J.
    Li, X.
    Zhou, C.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S409 - S410
  • [2] EGFR-TKIs plus chemotherapy demonstrated superior efficacy than EGFR-TKIs alone as first-line setting in advanced NSCLC patients with EGFR mutation and BIM deletion polymorphism
    Liu, Sangtian
    He, Yayi
    Jiang, Tao
    Ren, Shengxiang
    Zhou, Fei
    Zhao, Chao
    Li, Xuefei
    Zhang, Jie
    Su, Chunxia
    Chen, Xiaoxia
    Cai, Weijing
    Gao, Guanghui
    Li, Wei
    Wu, Fengying
    Li, Jiayu
    Zhao, Jing
    Hu, Qiong
    Zhao, Mingchuan
    Zhou, Caicun
    Hirsch, Fred R.
    LUNG CANCER, 2018, 120 : 82 - 87
  • [3] EGFR-TKIs or EGFR-TKIs combination treatments for untreated advanced EGFR-mutated NSCLC: a network meta-analysis
    Liu, Ao
    Wang, Xiaoming
    Wang, Lian
    Zhuang, Han
    Xiong, Liubo
    Gan, Xiao
    Wang, Qian
    Tao, Guanyu
    BMC CANCER, 2024, 24 (01)
  • [4] Combination of EGFR-TKIs with chemotherapy versus chemotherapy or EGFR-TKIs alone in advanced NSCLC patients with EGFR mutation
    Wen, Miaomiao
    Xia, Jinghua
    Sun, Ying
    Wang, Xuejiao
    Fu, Xianghui
    Zhang, Yanning
    Zhang, Zhipei
    Zhou, Yongan
    Li, Xiaofei
    BIOLOGICS-TARGETS & THERAPY, 2018, 12 : 183 - 190
  • [5] Liver Metastases Is the Negative Predictive Factor for First-Line EGFR TKIs Therapy in NSCLC Patients with EGFR Mutation
    Jiang, Tao
    Zhou, Caicun
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1246 - S1247
  • [6] Combination of EGFR-TKIs and chemotherapy in advanced EGFR mutated NSCLC: Review of the literature and future perspectives
    Rebuzzi, Sara Elena
    Alfieri, Roberta
    La Monica, Silvia
    Minari, Roberta
    Petronini, Pier Giorgio
    Tiseo, Marcello
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2020, 146
  • [7] Microwave ablation combined with EGFR-TKIs versus only EGFR-TKIs in advanced NSCLC patients with EGFR-sensitive mutations
    Wei, Zhigang
    Ye, Xin
    Yang, Xia
    Zheng, Aimin
    Huang, Guanghui
    Li, Wenhong
    Wang, Jiao
    Han, Xiaoying
    Meng, Min
    Ni, Yang
    ONCOTARGET, 2017, 8 (34) : 56714 - 56725
  • [8] Cost-effectiveness analysis of the first-line EGFR-TKIs in patients with advanced EGFR-mutated non-small-cell lung cancer
    Aguilar-Serra, J.
    Gimeno-Ballester, V
    Pastor-Clerigues, A.
    Milara, J.
    Trigo-Vicente, C.
    Cortijo, J.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2022, 22 (04) : 637 - 646
  • [9] Surgical Resection Improves the Survival of NSCLC Patients with Pleural Metastasis Treated with First-Line EGFR-TKIs
    Zhang, B.
    Xiao, Q.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (12) : S1051 - S1051
  • [10] Advanced NSCLC Patients at the Extremes of Age in the Era of EGFR-TKIs
    Chen, Yu-Mu
    Lai, Chien-Hao
    Chang, Huang-Chih
    Chao, Tung-Ying
    Tseng, Chia-Cheng
    Fang, Wen-Feng
    Chung, Yu-Hsiu
    Wang, Yi-Hsi
    Su, Mao-Chang
    Huang, Kuo-Tung
    Wang, Chin-Chou
    Lin, Meng-Chih
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1445 - S1445
12345